NCC-Bio is a South Korean biopharmaceutical company founded in 2020 and headquartered in Goyang, focused on developing targeted anti-cancer strategies and therapeutics.
Ranked competitors and alternatives for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see NCC-Bio →Already a subscriber? Sign in
Xcout Intel tracks NCC-Bio continuously — this profile deepens as new filings, funding, people and hiring data arrive.